Ronkonkkoma, NY–(ENEWSPF)–August 9, 2010. EZVille, Ltd. has been informed by the US Food and Drug Administration (FDA) that FDA lab analysis of Revivexxx® Extra Strength distributed by the company was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx® Extra Strength an unapproved drug.
FDA advises that this poses a threat to consumers because tadalafil may interact with nitrates found in some prescription drugs…
